tiprankstipranks
Trending News
More News >
AbbVie (DE:4AB)
XETRA:4AB
Germany Market
Advertisement

AbbVie (4AB) Technical Analysis

Compare
24 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
AbbVie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is 2.28, suggesting AbbVie is a Buy.
AbbVie’s (4AB) 20-Day exponential moving average is 195.34, while AbbVie’s (4AB) share price is €194.4, making it a Buy.
AbbVie’s (4AB) 50-Day exponential moving average is 188.72, while AbbVie’s (4AB) share price is €194.4, making it a Buy.

AbbVie (4AB) Pivot Points

Oct 30, 2025, 02:31 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
193.73
194.47
195.13
195.87
196.53
197.27
197.93
Fibonacci
194.47
195.00
195.33
195.87
196.40
196.73
197.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Oct 30, 2025, 02:31 PM
Period
Simple
Exponential
MA5
196.44Sell
196.25Sell
MA10
196.48Sell
196.47Sell
MA20
197.70Sell
195.34Buy
MA50
188.36Buy
188.72Buy
MA100
175.76Buy
181.18Buy
MA200
174.01Buy
176.63Buy
AbbVie’s (4AB) 10-Day exponential moving average is 196.47, while AbbVie’s (4AB) share price is €194.4, making it a Sell.
AbbVie’s (4AB) 100-Day exponential moving average is 181.18, while AbbVie’s (4AB) share price is €194.4, making it a Buy.
AbbVie’s (4AB) stock price is €194.4 and AbbVie’s (4AB) 50-day simple moving average is 188.36, creating a Buy signal.
AbbVie’s (4AB) stock price is €194.4 and AbbVie’s (4AB) 100-day simple moving average is 175.76, creating a Buy signal.
AbbVie’s (4AB) stock price is €194.4 and AbbVie’s (4AB) 200-day simple moving average is 174.01, creating a Buy signal.

AbbVie (4AB) Technical Indicators

Oct 30, 2025, 02:31 PM
Name
Value
Implied Action
RSI (14)
54.66
Neutral
STOCH (9,6)
41.35
Neutral
STOCHRSI (14)
34.75
Neutral
MACD (12,26)
2.28
Buy
ADX (14)
31.72
Neutral
Williams %R
-65.96
Buy
CCI (14)
-95.19
Neutral
ATR (14)
3.09
-
Ultimate Oscillator
47.92
Neutral
ROC
-0.89
Sell
AbbVie’s (4AB) Relative Strength Index (RSI) is 54.66, creating a Neutral signal.
AbbVie’s (4AB) Trend Strength Indicator (ADX) is 31.72, creating a Neutral signal.
AbbVie’s (4AB) Commodity Channel Index (CCI) is -95.19, creating a Neutral signal.
AbbVie’s (4AB) Price Rate of Change (ROC) is -0.89, creating a Sell signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Hold.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 54.66, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is 2.28, which suggests 4AB is a Buy.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 196.44, which suggests 4AB is a Sell.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 197.70, which suggests 4AB is a Sell.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 188.36, which suggests 4AB is a Buy.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 174.01, which suggests 4AB is a Buy.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -65.96, which suggests 4AB is a Buy.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is -95.19, which suggests 4AB is a Neutral.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis